Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6KMY

Structure of single disulfide peptide Czon1107-P5A

Summary for 6KMY
Entry DOI10.2210/pdb6kmy/pdb
DescriptorCzon1107-P5A (1 entity in total)
Functional Keywordsnachr anatgonist nmr, neuropeptide
Biological sourceConus zonatus
Total number of polymer chains1
Total formula weight1083.29
Authors
Sarma, S.P.,Madhan Kumar, M. (deposition date: 2019-08-01, release date: 2020-04-08, Last modification date: 2024-10-23)
Primary citationMohan, M.K.,Abraham, N.,R P, R.,Jayaseelan, B.F.,Ragnarsson, L.,Lewis, R.J.,Sarma, S.P.
Structure and allosteric activity of a single-disulfide conopeptide fromConus zonatusat human alpha 3 beta 4 and alpha 7 nicotinic acetylcholine receptors.
J.Biol.Chem., 295:7096-7112, 2020
Cited by
PubMed Abstract: Conopeptides are neurotoxic peptides in the venom of marine cone snails and have broad therapeutic potential for managing pain and other conditions. Here, we identified the single-disulfide peptides Czon1107 and Cca1669 from the venoms of and , respectively. We observed that Czon1107 strongly inhibits the human α3β4 (IC 15.7 ± 3.0 μm) and α7 (IC 77.1 ± 0.05 μm) nicotinic acetylcholine receptor (nAChR) subtypes, but the activity of Cca1669 remains to be identified. Czon1107 acted at a site distinct from the orthosteric receptor site. Solution NMR experiments revealed that Czon1107 exists in equilibrium between conformational states that are the result of a key Ser-Pro isomerization. Moreover, we found that the X-Pro amide bonds in the inter-cysteine loop are rigidly constrained to conformations. Structure-activity experiments of Czon1107 and its variants at positions P5 and P7 revealed that the conformation around the X-Pro bonds () plays an important role in receptor subtype selectivity. The conformation at the Cys-Pro peptide bond was essential for α3β4 nAChR subtype allosteric selectivity. In summary, we have identified a unique single-disulfide conopeptide with a noncompetitive, potentially allosteric inhibitory mechanism at the nAChRs. The small size and rigidity of the Czon1107 peptide could provide a scaffold for rational drug design strategies for allosteric nAChR modulation. This new paradigm in the "conotoxinomic" structure-function space provides an impetus to screen venom from other species for similar, short bioactive peptides that allosterically modulate ligand-gated receptor function.
PubMed: 32234761
DOI: 10.1074/jbc.RA119.012098
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon